# Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis

> **NCT01227863** · PHASE3 · UNKNOWN · sponsor: **Azidus Brasil** · enrollment: 70 (estimated)

## Conditions studied

- Bacterial Conjunctivitis
- Acute

## Interventions

- **DRUG:** MAXINOM®
- **DRUG:** Maxitrol®

## Key facts

- **NCT ID:** NCT01227863
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2011-02
- **Final completion:** —
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2010-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227863, "Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01227863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*